Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.60 Analyst target: $3.17 Upside: 425.73%
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA drugs to treat and protect people from diseases associated with the human papillomavirus (HPV), cancer, and infectious diseases.
See the full interactive analysis & chart →Informational only — not investment advice.